C4 Therapeutics Inc
NASDAQ:CCCC
C4 Therapeutics Inc
NASDAQ:CCCC
Price:
6.71 USD
-0.45%
Market Closed
Updated:
May 7, 2024
Operating Margin
C4 Therapeutics Inc
C4 Therapeutics Inc
-669.8%
Current
-405%
Average
-8.6%
Industry
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-669.8%
Operating Profit
/
-139m
Revenue
20.8m
Operating Margin Across Competitors
| Country | US |
| Market Cap | 460.3m USD |
| Operating Margin |
-670%
|
| Country | US |
| Market Cap | 286.9B USD |
| Operating Margin |
30%
|
| Country | US |
| Market Cap | 161B USD |
| Operating Margin |
24%
|
| Country | US |
| Market Cap | 105.9B USD |
| Operating Margin |
39%
|
| Country | US |
| Market Cap | 106.1B USD |
| Operating Margin |
30%
|
| Country | AU |
| Market Cap | 135.1B AUD |
| Operating Margin |
26%
|
| Country | US |
| Market Cap | 81.9B USD |
| Operating Margin |
32%
|
| Country | US |
| Market Cap | 45.7B USD |
| Operating Margin |
-100%
|
| Country | US |
| Market Cap | 43.1B USD |
| Operating Margin |
-33%
|
| Country | US |
| Market Cap | 31.6B USD |
| Operating Margin |
22%
|
| Country | KR |
| Market Cap | 40.3T KRW |
| Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for C4 Therapeutics Inc.
See Also
Discover More
What is Operating Margin?
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin
=-669.8%
Operating Profit
/
-139m
Revenue
20.8m
What is the Operating Margin of C4 Therapeutics Inc?
Based on C4 Therapeutics Inc's most recent financial statements, the company has Operating Margin of -669.8%.
You don't have any saved screeners yet
